Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada;
Felix
F
Leung
Department of Laboratory Medicine and Pathobiology, University of Toronto, and Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada;
Vathany
V
Kulasingam
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; ediamandis@mtsinai.on.ca.
Eleftherios P
EP
Diamandis
Professor, Director Molecular Oncology & Sequencing Center, John Wayne Cancer Institute, Saint Johns Health Center Providence, Santa Monica, CA;
Dave S B
DS
Hoon
Professor of Oncology, Director, Ludwig Center at Johns Hopkins University, The Johns Hopkins Kimmel Cancer Center, Baltimore, MD;
Kenneth
K
Kinzler
Professor, Director, Department of Tumor Biology, University of Hamburg, University Medical Center Hamburg-Eppendorf, Germany;
Klaus
K
Pantel
Associate Professor, University Medical Center of Montpellier, Hôpital Saint-Eloi - CHRU Montpellier, France.
Catherine
C
Alix-Panabières
D014408:Biomarkers, Tumor / Q000032:analysis*; D000074141:Circulating Tumor DNA / Q000032:analysis*; D006801:Humans; D009369:Neoplasms / Q000473:pathology*; D009360:Neoplastic Cells, Circulating / Q000473:pathology*
D014408:Biomarkers, Tumor; D000074141:Circulating Tumor DNA